Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization

Signal Transduct Target Ther. 2023 Feb 20;8(1):72. doi: 10.1038/s41392-022-01277-4.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO / genetics
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO / metabolism
  • Choroidal Neovascularization* / drug therapy
  • Choroidal Neovascularization* / genetics
  • Humans
  • RNA, Messenger / genetics
  • Vascular Endothelial Growth Factor A* / genetics
  • Vascular Endothelial Growth Factors

Substances

  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • FTO protein, human
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO